Development of Myasthenia Gravis due to Treatment of Chronic Hepatitis C with a Combination of Interferon-Alpha and Ribavirin

Development of Myasthenia Gravis due to Treatment of Chronic Hepatitis C with a Combination of Interferon-Alpha and Ribavirin

Copyright © 2006 S. Karger AG, Basel [PUBLICATION ABSTRACT]

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Digestion 2007-12, Vol.75 (4), p.208-209
Hauptverfasser: Bektas, M., Bektas, H., Gören, D., Altan, M., Cetinkaya, H.
Format: Artikel
Sprache:eng
Schlagworte:
Antiviral Agents - adverse effects
Diagnosis, Differential
Drug Therapy, Combination
Female
Hepatitis C, Chronic - drug therapy
Humans
Interferon-alpha - adverse effects
Letter to the Editor
Middle Aged
Myasthenia Gravis - chemically induced
Myasthenia Gravis - diagnosis
Ribavirin - adverse effects
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Copyright © 2006 S. Karger AG, Basel [PUBLICATION ABSTRACT]
ISSN:0012-2823
1421-9867
DOI:10.1159/000109410